Nascent Biotech Announces Successful Pritumumab In-Vitro Trial Data in Collaborative Covid-19 Treatment Study with Syracuse University

Press/Media: Expert Comment

PeriodFeb 17 2021

Media coverage

1

Media coverage

  • TitleNascent Biotech Announces Successful Pritumumab In-Vitro Trial Data in Collaborative Covid-19 Treatment Study with Syracuse University
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date2/17/21
    PersonsJennifer M Schwarz, Alison Patteson